---
title: "PLOS One Editorial Note: Concerns Raised Over Dexamethasone Study Figures"
id: "plos-one-20-editorial-note-dexamethasone-alleviates-tumor-associated-brain-damage-and"
canonical_url: "https://medichelpline.com/clinical-feed/plos-one-20-editorial-note-dexamethasone-alleviates-tumor-associated-brain-damage-and"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "PLOS ONE (Medicine)"
source_url: "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0363119"
published_at: "2026-11-19T14:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# PLOS One Editorial Note: Concerns Raised Over Dexamethasone Study Figures
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/plos-one-20-editorial-note-dexamethasone-alleviates-tumor-associated-brain-damage-and
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** PLOS ONE (Medicine)
- **Source URL:** [Original Journal Publication](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0363119)
- **Published At:** 2026-11-19T14:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- The PLOS One Editors published an Editorial Note regarding the 2014 article reporting that **Dexamethasone** alleviates **tumor-associated brain damage** and **angiogenesis**. - Editors stated that concerns have been raised specifically about results presented in **Fig 5C**. - The note also reports inaccuracies in the manuscript’s textual references to **Fig 6**. - The editorial notice does not provide granular detail about the nature of the concerns or the data in the figure panels. - The Editorial Note includes the full citation for the original 2014 paper by Fan et al.; readers are directed to the original article for full results. - The notice was published November 19, 2026, and is assigned DOI 10.1371/journal.pone.0363119. - The PLOS One Editors framed the item as an Editorial Note intended to inform readers of issues relevant to interpretation, rather than as a correction or retraction. - The source did not report whether an institutional investigation, author response, or formal correction is pending or completed. - The notice references related PLOS content linking back to the 2014 article and provides standard CrossMark and licensing information. - Readers are referred to the article page, metrics, comments, and media coverage links for further context; the Editorial Note itself limits its scope to flagging concerns and referencing inaccuracies.
## Clinical Analysis & Structured Key Points
[ Skip to main content ](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0363119#main-content) Advertisement * [plos.org](https://plos.org/) * [Create account](https://community.plos.org/registration/new) * [Sign in](https://journals.plos.org/user/secure/login?page=%2Fplosone%2Farticle%3Fid%3D10.1371%2Fjournal.pone.0363119) * * About * Browse * Publish * [](https://journals.plos.org/plosone/ "PLOS One") * Search [advanced search](https://journals.plos.org/plosone/search) * [Browse Topics](https://journals.plos.org/plosone/subjectAreaBrowse) Browse Subject Areas ? Click through the PLOS taxonomy to find articles in your field. For more information about PLOS Subject Areas, click [here](https://github.com/PLOS/plos-thesaurus/blob/master/README.md "Link opens in new window"). [](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0363119) [](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0363119) * 0 [Save](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0363119#savedHeader) [Total Mendeley and Citeulike bookmarks.](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0363119#savedHeader) * 0 [Citation](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0363119#citedHeader) [Paper's citation count computed by Dimensions.](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0363119#citedHeader) * 54 [View](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0363119#viewedHeader) [PLOS views and downloads.](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0363119#viewedHeader) * 0 [Share](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0363119#discussedHeader) [Sum of Facebook, Twitter, Reddit and Wikipedia activity.](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0363119#discussedHeader) Open Access Editorial Note Editorial Notes are published by PLOS to provide readers information relevant to an article’s interpretation. [See all article types » ](https://journals.plos.org/plosone/s/other-article-types) # Editorial Note: Dexamethasone alleviates tumor-associated brain damage and angiogenesis * The PLOS One Editors # Editorial Note: Dexamethasone alleviates tumor-associated brain damage and angiogenesis * The PLOS One Editors ![PLOS](https://journals.plos.org/resource/img/logo-plos-full-color.svg) x * Published: November 19, 2026 * * [Article](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0363119) * [Metrics](https://journals.plos.org/plosone/article/metrics?id=10.1371/journal.pone.0363119) * [Comments](https://journals.plos.org/plosone/article/comments?id=10.1371/journal.pone.0363119) * [Media Coverage](http://plos.altmetric.com/details/doi/10.1371/journal.pone.0363119) * [Reference](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0363119#reference) * [Reader Comments](https://journals.plos.org/plosone/article/comments?id=10.1371/journal.pone.0363119) The _PLOS One_ Editors issue this Editorial Note to inform readers that concerns have been raised about results presented in Fig 5C. Furthermore, there are inaccuracies in the textual references to Fig 6. ## Reference 1. 1. Fan Z, Sehm T, Rauh M, Buchfelder M, Eyupoglu IY, Savaskan NE. Dexamethasone alleviates tumor-associated brain damage and angiogenesis. PLoS One. 2014;9(4):e93264. pmid:24714627 * [ View Article ](https://doi.org/10.1371/journal.pone.0093264 "Go to article") * [ PubMed/NCBI ](http://www.ncbi.nlm.nih.gov/pubmed/24714627 "Go to article in PubMed") * [ Google Scholar ](http://scholar.google.com/scholar?q=Dexamethasone+alleviates+tumor-associated+brain+damage+and+angiogenesis+Fan+2014 "Go to article in Google Scholar") **Citation:** The _PLOS One_ Editors (2026) Editorial Note: Dexamethasone alleviates tumor-associated brain damage and angiogenesis. PLoS One 21(11): e0363119. https://doi.org/10.1371/journal.pone.0363119 **Published:** November 19, 2026 **Copyright:** © 2026 The PLOS One Editors. This is an open access article distributed under the terms of the [Creative Commons Attribution License](http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. [Download PDF](https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0363119&type=printable) * [Citation](https://journals.plos.org/plosone/article/citation?id=10.1371/journal.pone.0363119) * [XML](https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0363119&type=manuscript) [Print](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0363119) Share * [![Reddit](https://journals.plos.org/resource/img/icon.reddit.16.png)Reddit](https://www.reddit.com/submit?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0363119 "Submit to Reddit") * [![Facebook](https://journals.plos.org/resource/img/icon.fb.16.png)Facebook](https://www.facebook.com/share.php?u=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0363119&t=Editorial%20Note:%20Dexamethasone%20alleviates%20tumor-associated%20brain%20damage%20and%20angiogenesis "Share on Facebook") * [![LinkedIn](https://journals.plos.org/resource/img/icon.linkedin.16.png)LinkedIn](https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0363119&title=Editorial%20Note:%20Dexamethasone%20alleviates%20tumor-associated%20brain%20damage%20and%20angiogenesis&summary=Checkout%20this%20article%20I%20found%20at%20PLOS "Add to LinkedIn") * [![Mendeley](https://journals.plos.org/resource/img/icon.mendeley.16.png)Mendeley](https://www.mendeley.com/import/?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0363119 "Add to Mendeley") * [![Bluesky](https://journals.plos.org/resource/img/icon.bluesky.light.png)Bluesky](https://bsky.app/intent/compose?text=Checkout%20this%20article%20I%20found%20at%20PLOS:%20https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0363119 "Share on Bluesky") * ![Email](https://journals.plos.org/resource/img/icon.email.16.png)Email ![Check for updates via CrossMark](https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_BW_horizontal.svg) ### Related PLOS Articles * **COMMENTARY pertains to** * Dexamethasone Alleviates Tumor-Associated Brain Damage and Angiogenesis * [View Page](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0093264) * [PDF](https://journals.plos.org/plosone/article/file?type=printable&id=10.1371/journal.pone.0093264 "PDF opens in new window") Advertisement * [Publications](https://plos.org/our-journals/) * [PLOS Aging and Health](https://journals.plos.org/agingandhealth/) * [PLOS Biology](https://journals.plos.org/plosbiology/) * [PLOS Climate](https://journals.plos.org/climate/) * [PLOS Complex Systems](https://journals.plos.org/complexsystems/) * [PLOS Computational Biology](https://journals.plos.org/ploscompbiol/) * [PLOS Digital Health](https://journals.plos.org/digitalhealth/) * [PLOS Ecosystems](https://journals.plos.org/ecosystems/) * [PLOS Genetics](https://journals.plos.org/plosgenetics/) * [PLOS Global Public Health](https://journals.plos.org/globalpublichealth/) * [PLOS Medicine](https://journals.plos.org/plosmedicine/) * [PLOS Mental Health](https://journals.plos.org/mentalhealth/) * [PLOS Neglected Tropical Diseases](https://journals.plos.org/plosntds/) * [PLOS One](https://journals.plos.org/plosone/) * [PLOS Pathogens](https://journals.plos.org/plospathogens/) * [PLOS Sustainability and Transformation](https://journals.plos.org/sustainabilitytransformation/) * [PLOS Water](https://journals.plos.org/water/) * [Home](https://plos.org) * [Blogs](https://blogs.plos.org) * [Collections](https://collections.plos.org/) * Give feedback * [LOCKSS](https://journals.plos.org/plosone/lockss-manifest) * [Privacy Policy](https://plos.org/privacy-policy) * [Terms of Use](https://plos.org/terms-of-use) * [Advertise](https://plos.org/advertise/) * [Media Inquiries](https://plos.org/media-inquiries) * [Contact](https://plos.org/contact) ![PLOS](https://journals.plos.org/resource/img/logo-plos-footer.png) PLOS is a nonprofit 501(c)(3) corporation, #C2354500, based in California, US ![PLOS Logo](data:image/svg+xml;charset=utf-8;base64,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) ### Cookie Preference Center Our website uses different types of cookies. Optional cookies will only be set with your consent and you may withdraw this consent at any time. Below you can learn more about the types of cookies PLOS uses and register your cookie preferences. Accept All Cookies ### Customize Your Cookie Preference +**Strictly Necessary** Always On +**Functional** OnOff +**Performance and Analytics** OnOff +**Marketing** OnOff Save Selected Preferences and Close [For more information about the cookies and other technologies used by us, please read our Cookie Policy.](https://plos.org/cookies-policy) ![](https://bat.bing.com/action/0?ti=343272436&tm=gtm002&Ver=2&mid=df6feb85-cfa3-42ed-aa5d-3b0830d66471&bo=1&sid=390412d0e4a411f1a1529392819fd1fe&vid=39046860e4a411f1bf726927ccf73420&vids=0&msclkid=N&gtm_tag_source=1&pi=0&lg=en-US&sw=1080&sh=600&sc=24&tl=Editorial%20Note%3A%20Dexamethasone%20alleviates%20tumor-associated%20brain%20damage%20and%20angiogenesis%20%7C%20PLOS%20One&p=https%3A%2F%2Fjournals.plos.org%2Fplosone%2Farticle%3Fid%3D10.1371%2Fjournal.pone.0363119&r=&lt=2884&evt=pageLoad&sv=2&cdb=AQAQ&rn=811961)
## Related Clinical Research

- [Glucocorticoid signaling and microRNA networks in acute lymphoblastic leukemia: GAO078 model findi](https://medichelpline.com/clinical-feed/pubmed-43059396.md) (DOI: 10.3892/ijo.2026.5963)
- [Teclistamab in high-risk smouldering multiple myeloma: assessing whether deep responses can preven](https://medichelpline.com/clinical-feed/nature-reviews-clinical-oncology-0-t-cell-redirection-in-high-risk-smouldering-multiple-myeloma-can-deep-responses.md)
- [Control-arm mismatches in NCI multiple myeloma randomized trials](https://medichelpline.com/clinical-feed/nature-reviews-clinical-oncology-0-problematic-control-arms-in-national-cancer-institute-myeloma-trials.md)
- [Aquaporin-4 (AQP4) Modulates Edema, Astrocyte State, and Immune Remodeling in Glioblastoma](https://medichelpline.com/clinical-feed/biorxiv-7-aquaporin-4-regulates-edema-sustains-astrocyte-differentiation-and-constrains.md)
- [Angioimmunoblastic T‑cell Lymphoma Complicated by Secondary HLH Initially Misdiagnosed as Classica](https://medichelpline.com/clinical-feed/pubmed-42826277.md) (DOI: 10.1097/MD.0000000000050979)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.